Abstract B014: Therapeutic Reversal of Tumor Cell Plasticity by EHF mRNA Delivery in Prostate Cancer
This strategy represents a first-in-class opportunity to target tumor plasticity and overcome resistance in advanced prostate cancer with a defined biomarker framework (low EHF expression, plasticity signatures) and compatibility with various delivery platforms.